Advertisement

Topics

UK Charity Starts Early-Stage Clinical Studies Of Lilly's Cdc7 Inhibitor

03:22 EDT 23 Aug 2017 | SCRIP

The drug development arm of the UK charity, Cancer Research UK, has started early clinical development of potentially a new...

      

Related Stories

 

Original Article: UK Charity Starts Early-Stage Clinical Studies Of Lilly's Cdc7 Inhibitor

NEXT ARTICLE

More From BioPortfolio on "UK Charity Starts Early-Stage Clinical Studies Of Lilly's Cdc7 Inhibitor"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...

Cancer Disease
Cancer is not just one disease but many diseases. There are more than 100 different types of cancer. Most cancers are named for the organ or type of cell in which they start - for example, cancer that begins in the colon is called colon cancer; cancer th...